Skip to main content

Advertisement

Table 1 Inclusion and exclusion criteria for donors

From: Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel

Inclusion criteria for clopidogrel donors Inclusion criteria for age matched control donors Exclusion criteria
Clopidogrel or clopidogrel and aspirin use for at least 14 days prior to blood draw No clopidogrel use for at least 14 days prior to blood draw History of diabetes, renal failure, acute or chronic liver disease, including acute or chronic hepatitis or cirrhosis
If on aspirin, daily aspirin dosage of at least 75 mg/day No aspirin use for at least 14 days prior to blood draw Positive for HIV, hepatitis B, or hepatitis C
Males and Females Males and Females Use of Selective Serotonin Re-uptake Inhibitors (SSRIs), Seritonin-Norepinepherin Re-uptake Inhibitors (SNRIs), Omeprazole (which interferes with clopidogrel metabolism) [25], or oral anticoagulants (Coumadin, Warfarin, etc.)